FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2024
Voltar para busca
Dado oficial do USPTO
HFL NEXT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
21/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
19/11/2021
Data de registro
30/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2024
Última transação
30/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Harrow, Middlesex, GB
Examinador
LAVACHE, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Health First Laboratories Ltd
Representantes
Bradley M. Stohry Reichel Stohry Dean LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medical testing apparatusequipment and instrumentsmedical diagnostic apparatus for testing fecal immunochemical levelsmedical diagnostic apparatus for testing for human papillomavirusmedical diagnostic apparatus for bowel cancer screeningmedical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for respiratory viral disease screening; home and self-testing apparatusequipment and instruments for medical usemedical diagnostic apparatus for testing fecal immunochemical levelsmedical diagnostic apparatus for testing for human papillomavirusmedical diagnostic apparatus for bowel cancer screeningmedical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for viral respiratory disease screening; home and self-testing kits for medical usecomprised of medical diagnostic apparatus for testing fecal immunochemical levelsmedical diagnostic apparatus for testing for human papillomavirusmedical diagnostic apparatus for bowel cancer screeningmedical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for respiratory viral disease screening; lateral flow medical testing apparatus for detecting coronavirus (COVID-19); medical sampling apparatus for testing fecal immunochemical levelsfor testing for human papillomavirusfor bowel cancer screeningfor lateral flow immunoassay testing and for respiratory viral disease screening; lateral flow test kits comprised of medical diagnostic apparatus for detecting coronavirus (COVID-19); medical testing apparatusequipment and instruments for bowel cancer screening; medical sampling apparatusequipment and instruments for bowel cancer screening; medical apparatusequipment and instruments for respiratory viral disease screening; faecal immunochemical testing apparatusequipment and instruments for medical use; home and self-testing faecal immunochemical testing apparatusequipment and instruments for medical use; human papillomavirus testing apparatusequipment and instruments for medical use; home and self-testing human papillomavirus testing apparatusequipment and instruments for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2024
FIMP
FINAL DISPOSITION PROCESSED
30/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBO
PUBLISHED FOR OPPOSITION
14/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/09/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
21/07/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
28/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/06/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/06/2023
GNFR
FINAL REFUSAL E-MAILED
07/06/2023
CNFR
FINAL REFUSAL WRITTEN
07/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2023
RFNT
REFUSAL PROCESSED BY IB
27/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2022
RFRR
REFUSAL PROCESSED BY MPU
04/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2022
CNRT
NON-FINAL ACTION WRITTEN
08/09/2022
DOCK
ASSIGNED TO EXAMINER
31/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HFL NEXT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.